UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Under-reporting of adverse drug reactions : A systematic review

Drug safety, 2006-01, Vol.29 (5), p.385-396

2006

Volltextzugriff (PDF)

Modified Prescription-Event Monitoring Studies: A Tool for Pharmacovigilance and Risk Management

Drug safety, 2011-12, Vol.34 (12), p.e1-e9

2011

Volltextzugriff (PDF)

Risk of Depressive Episodes with Rimonabant: A Before and After Modified Prescription Event Monitoring Study Conducted in England

Drug safety, 2011-06, Vol.34 (6), p.501-509

2011

Volltextzugriff (PDF)

Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia : A model for assessing causal association in pharmacovigilance

Drug safety, 2007-01, Vol.30 (4), p.333-346

2007

Volltextzugriff (PDF)

Incidence of Venous Thromboembolism in Users of Strontium Ranelate: An Analysis of Data from a Prescription-Event Monitoring Study in England

Drug safety, 2010-07, Vol.33 (7), p.579-591

2010

Volltextzugriff (PDF)

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets

Drug safety, 2006-01, Vol.29 (2), p.175-181

2006

Volltextzugriff (PDF)

Serious skin reactions and selective COX-2 inhibitors : A case series from prescription-event monitoring in England

Drug safety, 2006-01, Vol.29 (8), p.687-696

2006

Volltextzugriff (PDF)

Examining the Utilization and Tolerability of the Non-Sedating Antihistamine Levocetirizine in England Using Prescription-Event Monitoring Data

Drug safety, 2011-12, Vol.34 (12), p.1177-1189

2011

Volltextzugriff (PDF)

Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands

Drug safety, 2008-01, Vol.31 (2), p.143-158

2008

Volltextzugriff (PDF)

Safety profile of rosuvastatin : Results of a prescription-event monitoring study of 11 680 patients

Drug safety, 2007, Vol.30 (2), p.157-170

2007

Volltextzugriff (PDF)

Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine : A prescription-event monitoring study in England

Drug safety, 2006-01, Vol.29 (10), p.897-909

2006

Volltextzugriff (PDF)

Drug Utilization of Intrinsa® (Testosterone Patch) in England: Interim Analysis of a Prescription-Event Monitoring Study to Support Risk Management

Drug safety, 2010-03, Vol.33 (3), p.213-221

2010

Volltextzugriff (PDF)

Safety Profile of Esomeprazole: Results of a Prescription-Event Monitoring Study of 11 595 Patients in England

Drug safety, 2008, Vol.31 (4), p.313-323

2008

Volltextzugriff (PDF)

Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England

Drug safety, 2008-01, Vol.31 (10), p.839-850

2008

Volltextzugriff (PDF)

Thoughts on signal detection in pharmacovigilance

Drug safety, 2007-01, Vol.30 (7), p.603-606

SHAKIR, Saad A. W

2007

Volltextzugriff (PDF)

Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology

Drug safety, 2004-01, Vol.27 (7), p.427-456

2004

Volltextzugriff (PDF)

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

Drug safety, 2021-08, Vol.44 (8), p.835-841

2021

Volltextzugriff (PDF)

Safety of zafirlukast : Results of a postmarketing surveillance study on 7976 patients in England

Drug safety, 2007-01, Vol.30 (5), p.419-429

2007

Volltextzugriff (PDF)

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

British journal of rheumatology, 2003-11, Vol.42 (11), p.1354-1364

2003

Volltextzugriff (PDF)

Bill Inman: drug safety physician and pharmacoepidemiologist

Drug safety, 2006, Vol.29 (3), p.187

Shakir, Saad A W

2006

Volltextzugriff (PDF)

A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data

Drug safety, 2005-01, Vol.28 (9), p.803-816

2005

Volltextzugriff (PDF)

Ophthalmological events in patients receiving risedronate : Summary of information gained through follow-up in a prescription-event monitoring study in England

Drug safety, 2006-01, Vol.29 (2), p.151-160

2006

Volltextzugriff (PDF)

A modified prescription-event monitoring study to assess the introduction of seretide evohaler™ in england : An example of studying risk monitoring in pharmacovigilance

Drug safety, 2007, Vol.30 (8), p.681-695

2007

Volltextzugriff (PDF)

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19

Frontiers in pharmacology, 2021-01, Vol.11, p.569189

2021

Volltextzugriff (PDF)

Specialist Cohort Event Monitoring Studies: A New Study Method for Risk Management in Pharmacovigilance

Drug safety, 2015-02, Vol.38 (2), p.153-163

2015

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(79)
Buchkapitel
(5)

Sprache

Englisch
(84)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(69)
Science & Technology
(69)
Humans
(65)
Pharmacology & Pharmacy
(55)
Biological And Medical Sciences
(51)
Medical Sciences
(51)
Male
(47)
Pharmacology. Drug Treatments
(46)
Female
(45)
Middle Aged
(44)
Cohort Studies
(39)
Public, Environmental & Occupational Health
(37)
Adult
(34)
Toxicology
(34)
Aged
(33)
Drug Toxicity And Drugs Side Effects Treatment
(31)
England
(26)
Drug Safety And Pharmacovigilance
(21)
Medicine
(21)
Medicine & Public Health
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Under-reporting of adverse drug reactions : A systematic review

Modified Prescription-Event Monitoring Studies: A Tool for Pharmacovigilance and Risk Management

Risk of Depressive Episodes with Rimonabant: A Before and After Modified Prescription Event Monitoring Study Conducted in England

Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia : A model for assessing causal association in pharmacovigilance

Incidence of Venous Thromboembolism in Users of Strontium Ranelate: An Analysis of Data from a Prescription-Event Monitoring Study in England

An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets

Serious skin reactions and selective COX-2 inhibitors : A case series from prescription-event monitoring in England

Examining the Utilization and Tolerability of the Non-Sedating Antihistamine Levocetirizine in England Using Prescription-Event Monitoring Data

Evaluation of Risk Profiles for Gastrointestinal and Cardiovascular Adverse Effects in Nonselective NSAID and COX-2 Inhibitor Users: A Cohort Study Using Pharmacy Dispensing Data in The Netherlands

Safety profile of rosuvastatin : Results of a prescription-event monitoring study of 11 680 patients

Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine : A prescription-event monitoring study in England

Drug Utilization of Intrinsa® (Testosterone Patch) in England: Interim Analysis of a Prescription-Event Monitoring Study to Support Risk Management

Safety Profile of Esomeprazole: Results of a Prescription-Event Monitoring Study of 11 595 Patients in England

Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England

Thoughts on signal detection in pharmacovigilance

Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

Safety of zafirlukast : Results of a postmarketing surveillance study on 7976 patients in England

Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data

Bill Inman: drug safety physician and pharmacoepidemiologist

A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data

Ophthalmological events in patients receiving risedronate : Summary of information gained through follow-up in a prescription-event monitoring study in England

A modified prescription-event monitoring study to assess the introduction of seretide evohaler™ in england : An example of studying risk monitoring in pharmacovigilance

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19

Specialist Cohort Event Monitoring Studies: A New Study Method for Risk Management in Pharmacovigilance

Suchergebnisse filtern